Biogen Inc (NASDAQ:BIIB) over-valued by 11%
| Website | https://www.biogen.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $41,449,299,968 |
| Beta | 0.436845 |
| Average Volume | $1,154,198 |
| Last Dividend | 0% |
| Price on Apr 22, 2021 | $275.31 |
| Autochartist™ Valuation | $245.13 |
| Conclusion |
11% over-valued |
| Download Report |
